Total Antioxidant Capacity in HBV Carriers, a Promising Biomarker for Evaluating Hepatic Fibrosis: A Pilot Study
Open Access
- 8 January 2021
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 10 (1) , 77
Abstract
Oxidative stress plays a pivotal role in the progression of chronic hepatitis B; however, it is unclear whether the status of blood oxidative stress and antioxidant components differs depending on the degree of hepatic fibrosis. To explore the relationship between oxidative stress/antioxidant capacity and the extent of hepatic fibrosis, fifty-four subjects with liver fibrosis (5.5 ≤ liver stiffness measurement (LSM) score ≤ 16.0 kPa) by chronic hepatitis B virus (HBV) were analyzed. From the analysis of eight kinds of serum oxidative stress/antioxidant profiles and liver fibrosis degrees, the level of total antioxidant capacity (TAC) reflected a negative correlation with the severity of hepatic fibrosis (Pearson correlation, r = −0.35, p = 0.01). Moreover, TAC showed higher sensitivity (73.91%) than the aspartate transaminase (AST) to platelet ratio index (APRI, 56.52%) in the receiver operating characteristic (ROC) curves. Interestingly, the TAC level finely reflected the fibrosis degree in inactive carriers (HBV DNA < 2000 IU/mL), while the APRI did in active carriers (HBV DNA > 2000 IU/mL). In conclusion, TAC is a promising biomarker for evaluating the progression of liver fibrosis in patients with HBV, and this finding may indicate the involvement of TAC-composing factors in the pathogenesis of hepatic fibrosis in chronic HBV carriers.Keywords
Funding Information
- National Research Foundation of Korea (2019R1A2C2088201)
This publication has 46 references indexed in Scilit:
- Relationship of Oxidative Stress in Hepatitis B Infection Activity with HBV DNA and FibrosisAnnals of Laboratory Medicine, 2012
- The Management of Chronic Hepatitis B in Asian AmericansDigestive Diseases and Sciences, 2011
- Antioxidants as therapeutic agents for liver diseaseLiver International, 2011
- Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriersVirology Journal, 2011
- Efficient Assay for Total Antioxidant Capacity in Human Plasma Using a 96-Well MicroplateJournal of Clinical Biochemistry and Nutrition, 2009
- DNA-guided hepatitis B treatment, viral load is essential, but not sufficientWorld Journal of Gastroenterology, 2009
- High-throughput spectrophotometric assay of reactive oxygen species in serumMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2007
- Transient elastography: a valid alternative to biopsy in patients with chronic liver diseaseAlimentary Pharmacology & Therapeutics, 2006
- Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysisJournal of Evaluation in Clinical Practice, 2006
- Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric methodClinica Chimica Acta, 1978